Piper Sandler Reiterates Overweight Rating on Crinetics (CRNX)

October 14, 2024 7:27 AM UTC Send to a Friend
Piper Sandler analyst Yasmeen Rahimi reiterated an Overweight rating and $97.00 price target on Crinetics (NASDAQ: CRNX).The analyst commented, "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login